EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H25N |
| Net Charge | 0 |
| Average Mass | 303.449 |
| Monoisotopic Mass | 303.19870 |
| SMILES | CCN1CCC(=C2c3ccccc3CCc3ccccc32)C1C |
| InChI | InChI=1S/C22H25N/c1-3-23-15-14-19(16(23)2)22-20-10-6-4-8-17(20)12-13-18-9-5-7-11-21(18)22/h4-11,16H,3,12-15H2,1-2H3 |
| InChIKey | NKJQZSDCCLDOQH-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. |
| Applications: | muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. antiparkinson drug A drug used in the treatment of Parkinson's disease. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| piroheptine (CHEBI:135287) has role antiparkinson drug (CHEBI:48407) |
| piroheptine (CHEBI:135287) has role muscarinic antagonist (CHEBI:48876) |
| piroheptine (CHEBI:135287) is a N-alkylpyrrolidine (CHEBI:46775) |
| piroheptine (CHEBI:135287) is a carbotricyclic compound (CHEBI:38032) |
| piroheptine (CHEBI:135287) is conjugate base of piroheptine(1+) (CHEBI:176970) |
| Incoming Relation(s) |
| piroheptine(1+) (CHEBI:176970) is conjugate acid of piroheptine (CHEBI:135287) |
| IUPAC Name |
|---|
| 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-1-ethyl-2-methylpyrrolidine |
| INNs | Source |
|---|---|
| piroheptine | WHO MedNet |
| piroheptina | WHO MedNet |
| piroheptinum | WHO MedNet |
| piroheptine | WHO MedNet |
| Manual Xrefs | Databases |
|---|---|
| 2208 | DrugCentral |
| D08395 | KEGG DRUG |
| Piroheptine | Wikipedia |
| 4688 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| CAS:16378-21-5 | ChemIDplus |
| Citations |
|---|